A Clear Path Across the Atlantic

The Client's Situation

The client had built a genuinely elegant piece of technology: a controlled, scalable cultivation platform that grows photosynthetically active plant material under tightly regulated environmental conditions, enabling continuous biomass production of consistent quality. From that biomass they isolate and recover valuable phytochemicals — including polyphenolic compounds — which are purified and formulated as naturally sourced, biologically active ingredients for cosmetic, nutraceutical, food, agricultural and pharmaceutical use.

In their home European market, the product was established. Now they were preparing to expand into North America — a large, attractive market, and a much more heavily patented one.

They did the responsible thing, and they did it in the right order. Before committing to a launch, they came to us with a single question: is our path clear? Were there any active patents in North America that our client's process, product or applications might infringe — anything that could block, delay, or add unexpected cost to the launch?

The Complication

The difficulty in a study like this is not finding a patent. It is being confident you have found all the ones that matter — and correctly cleared the ones that don't.

Two features of this technology made that harder than a routine clearance.

First, the breadth of the invention. This was not a single product. It was a platform spanning several distinct technical stages — the cultivation system and its environmental controls, the continuous biomass production method, the extraction and purification of phytochemicals, and the downstream formulations. Patents could sit in the path at any of those stages, and a clearance that examined only the end product while ignoring the process — or vice versa — would be dangerously incomplete.

Second, the breadth of application. The same bioactive compound destined for a cosmetic might read on patents in the nutraceutical, food or pharmaceutical spaces. The relevant patent landscape was not one field but the overlap of several.

And underlying both was the rule that makes FTO its own discipline: patent rights are territorial and claim-specific. The client's clean position in Europe said nothing about North America, and only the claims of active North American patents — not their abstracts, not their titles — could determine whether a real obstacle existed.

The Turn

We scoped the search to the client's actual commercial plans, then went wide enough to be sure.

We deconstructed the platform into its clearable elements — cultivation system and environmental control, continuous biomass production, phytochemical extraction and purification, and the target formulations — so that each stage of the client's process and product could be cleared on its own terms rather than lost inside a single broad query.

We searched active patent rights in the relevant North American jurisdiction(s), focusing on in-force patents and pending applications capable of maturing into enforceable rights in the client's launch timeframe.

We read on the claims, not the concepts. For every patent that surfaced as potentially relevant, our analysts examined the independent claims against the client's specific process and product features, element by element, to determine whether the client's activity would actually fall within scope — the distinction between a patent that merely mentions polyphenols and one whose claims would genuinely be infringed.

We accounted for the application spread, checking the phytochemical products and formulations across the cosmetic, nutraceutical, food, agricultural and pharmaceutical spaces the client intended to enter.

Throughout, the standard was honesty over reassurance. Had we found a blocking patent, we would have brought it to the client early — with an assessment of its strength and the options around it (design-around, a validity challenge, or a licensing conversation), exactly as our FTO methodology requires.

The Outcome

The search returned a clean result. Across the client's process, product and intended applications, we identified no active patent rights presenting a freedom-to-operate obstacle to the North American launch, as of the search date.

We delivered that conclusion with the reasoning behind it — the scope searched, the claims reviewed, and the appropriate caveat that an FTO clearance reflects the patent landscape published at the time of the search and cannot account for applications not yet published. The client understood exactly what they had: not a blank guarantee, but a well-founded, evidenced clearance on which a confident commercial decision could rest.

They launched their product in North America on schedule.